SIALLAC
LIVE

Serial Number

97794193

Owner

GENECHEM INC.

Attorney

JONG PARK

Filing Date

Feb 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SIALLAC Trademark

Serial Number: 97794193 • Registration: 7790003

SIALLAC is a trademark filed by GENECHEM INC. on February 14, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GENECHEM INC. (2 trademarks)

A-201, 187, Techno 2-ro, Yuseong-gu,
Daejeon 34025 , KR

Entity Type: 03

Trademark Details

Filing Date

February 14, 2023

Registration Date

May 13, 2025

Published for Opposition

March 25, 2025

Goods & Services

Dietary supplements with a cosmetic effect; food supplements; dietary supplemental drinks; dietary supplements comprising nutritive substances; dietary supplements; nutraceuticals for use as dietary supplements; dietary fiber to aid digestion; dietary and nutritional supplements; medicated confectionery; [ infant formula; powdered milk foods for infants; food for babies; beverages for infants in the nature of liquid formula ] nutritional supplements; food supplements for medical purposes; dietary and nutritionally fortified breads and bakery goods, gluten free bakery goods, sports drinks, isotonic drinks, and energy drinks, breakfast cereals, instant and ready-to-eat cereals, dairy-based beverages, frozen dairy desserts being ice cream, gelatin desserts, dessert puddings, and chocolate fillings for bakery products, milk products, low-sodium soups and broths, sugar- free and low-carb granola snacks, high-fiber processed cereals, fortified processed cereals, calorically dense shakes, dietetic foods, all adapted for medical purposes; nutritionally fortified beverages for medical purposes; sweets for medicinal purposes; colostrum dietary supplements; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment of digestive weakness, bowel discomfort, mild gastrointestinal tract inflammation, healthy digestive system, immune system function, brain and cognition development, inflammation in muscles and joints * ; all of the foregoing for use in connection with adult dietary supplements and none of the foregoing for infants or babies or administered in liquid or powder form or consisting of or including supplements, nutraceuticals, food, beverages, or fiber for infants or babies *

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Apr 28, 2026 NURC
AMENDMENT UNDER SECTION 7 - PROCESSED
Apr 7, 2026 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 7, 2026 APRE
TTAB RELEASE CASE TO TRADEMARKS
Apr 7, 2026 TMBN
CANCELLATION TERMINATED NO. 999999
Apr 7, 2026 CANT
CANCELLATION DENIED NO. 999999
Apr 7, 2026 CAND
CANCELLATION INSTITUTED NO. 999999
Dec 10, 2025 PETC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 13, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 13, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 19, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 30, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 22, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 28, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 28, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 28, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 26, 2024 CRFA
ASSIGNED TO LIE
Oct 26, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 24, 2024 ERSI
CORRESPONDENCE E-MAILED
Feb 13, 2024 GRML
SUSPENSION LETTER WRITTEN
Feb 13, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 14, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 13, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2023 NWOS
NEW APPLICATION ENTERED
Feb 17, 2023 NWAP